PMP22 expression in dermal nerve myelin from patients with CMT1A

Brain

Volumn 132, Issue 7, 2009, Pages 1734-1740

  Katona, Istvan ^a   Wu, Xingyao ^a   Feely, Shawna M E ^a   Sottile, Stephanie ^a   Siskind, Carly E ^a   Miller, Lindsey J ^a   Shy, Michael E ^a   Li, Jun ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Charcot Marie Tooth disease; CMT1A; CMTNS; HNPP; Myelin; PMP22; Schwann cell

Indexed keywords

MESSENGER RNA; MYELIN; PERIPHERAL MYELIN PROTEIN 22;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENE DISRUPTION; GENE OVEREXPRESSION; GENETIC DISORDER; HEREDITARY MOTOR SENSORY NEUROPATHY; HEREDITARY MOTOR SENSORY NEUROPATHY TYPE 1A; HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSY; HUMAN; HUMAN TISSUE; NEUROLOGIC DISEASE; NEUROPATHY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SKIN BIOPSY; SKIN NERVE;

BIOLOGICAL MARKERS; CHARCOT-MARIE-TOOTH DISEASE; HEREDITARY MOTOR AND SENSORY NEUROPATHIES; HUMANS; MICROSCOPY, IMMUNOELECTRON; MYELIN PROTEINS; MYELIN SHEATH; PROSPECTIVE STUDIES; RNA, MESSENGER; SCHWANN CELLS; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 67650045535     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awp113     Document Type: Article

References (50)

1. Behse F, Buchthal F, Carlsen F, Knappeis GG. Hereditary neuropathy with liability to pressure palsies. Electrophysiological and histopathological aspects. Brain 1972; 95: 777-94.
2. Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993; 72: 143-51.
3. D'Urso D, Ehrhardt P, Muller HW. Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin. J Neurosci 1999; 19: 3396-403.
4. Fewings JD, Blumbergs PC, Mukherjee TM, Hallpike JF. Tomaculous neuropathy: hereditary predisposition to pressure palsies. Aust N Z J Med 1985; 15: 598-603.
5. Gabreels-Festen AA, Bolhuis PA, Hoogendijk JE, Valentijn LJ, Eshuis EJ, Gabreels FJ. Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol 1995; 90: 645-9.
6. Gabreels-Festen A, van Beersum S, Eshuis L, LeGuern E, Gabreels F, van Engelen B, et al. Study on the gene and phenotypic characterisation of autosomal recessive demyelinating motor and sensory neuropathy (Charcot-Marie-Tooth disease) with a gene locus on chromosome 5q23-q33. J Neurol Neurosurg Psychiatry 1999; 66: 569-74.
7. Gabriel JM, Erne B, Pareyson D, Sghirlanzoni A, Taroni F, Steck AJ. Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies. Neurology 1997; 49: 1635-40.
8. Garcia CA, Malamut RE, England JD, Parry GS, Liu P, Lupski JR. Clinical variability in two pairs of identical twins with the Charcot-Marie- Tooth disease type 1A duplication. Neurology 1995; 45: 2090-3.
9. Grandis M, Vigo T, Passalacqua M, Jain M, Scazzola S, La Padula V, et al. Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations. Hum Mol Genet 2008; 17: 1877-89.
10. Hanemann CO, Stoll G, D'Urso D, Fricke W, Martin JJ, Van Broeckhoven C, et al. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies. J Neurosci Res 1994; 37: 654-9.
11. Hasse B, Bosse F, Hanenberg H, Muller HW. Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions. Mol Cell Neurosci 2004; 27: 370-8.
12. Inoue K, Dewar K, Katsanis N, Reiter LT, Lander ES, Devon KL, et al. The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes. Genome Res 2001; 11: 1018-33.
13. Ionasescu VV, Ionasescu R, Searby C, Barker DF. Charcot-Marie-Tooth neuropathy type 1A with both duplication and non-duplication. Hum Mol Genet 1993; 2: 405-10.
14. Jani-Acsadi A, Krajewski K, Shy ME. Charcot-Marie-Tooth neuropathies: diagnosis and management. Semin Neurol 2008; 28: 185-94.
15. Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, et al. Neurological dysfunction and axonal degeneration in Charcot- Marie-Tooth disease type 1A. Brain 2000; 123 (Pt 7): 1516-27.
16. Li J, Bai Y, Ghandour K, Qin P, Grandis M, Trostinskaia A, et al. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside. Brain 2005; 128: 1168-77.
17. Li J, Ghandour K, Radovanovic D, Shy RR, Krajewski KM, Shy ME, et al. Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies. Arch Neurol 2007; 64: 974-8.
18. Li J, Krajewski K, Lewis RA, Shy ME. Loss-of-function phenotype of hereditary neuropathy with liability to pressure palsies. Muscle Nerve 2004; 29: 205-10.
19. Lombardi R, Erne B, Lauria G, Pareyson D, Borgna M, Morbin M, et al. IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy. Ann Neurol 2005; 57: 180-7.
20. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991; 66: 219-32.
21. Lupski JR, Garcia CA. Molecular genetics and neuropathology of Charcot-Marie-Tooth disease type 1A. Brain Pathol 1992; 2: 337-49.
22. Madrid R, Bradley WG. The pathology of neuropathies with focal thickening of the myelin sheath (tomaculous neuropathy), studies on the formation of the abnormal myelin sheath. J Neurol Sci 1975; 25:415-48.
23. Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet 1995; 11:281-6.
24. Meyer zu Horste G, Prukop T, Liebetanz D, Mobius W, Nave KA, Sereda MW. Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Ann Neurol 2007; 61: 61-72.
25. Nelis E, Van Broeckhoven C, De Jonghe P, Lofgren A, Vandenberghe A, Latour P, et al. Estimation of the mutation frequencies in Charcot- Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet 1996; 4: 25-33.
26. Nolano M, Provitera V, Crisci C, Stancanelli A, Wendelschafer-Crabb G, Kennedy WR, et al. Quantification of myelinated endings and mechanoreceptors in human digital skin. Ann Neurol 2003; 54:197-205.
27. Pareek S, Notterpek L, Snipes GJ, Naef R, Sossin W, Laliberte J, et al. Neurons promote the translocation of peripheral myelin protein 22 into myelin. J Neurosci 1997; 17: 7754-62.
28. Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 2004; 10:396-401.
29. Pennuto M, Tinelli E, Malaguti M, Del Carro U, D'Antonio M, Ron D, et al. Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice. Neuron 2008; 57: 393-405.
30. Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, et al. Duplication in chromosome 17p11.2 in Charcot-Marie- Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord 1991; 1: 93-7.
31. Raeymaekers P, Timmerman V, Nelis E, Van Hul W, De Jonghe P, Martin JJ, et al. Estimation of the size of the chromosome 17p11.2 duplication in Charcot-Marie-Tooth neuropathy type 1a (CMT1a). HMSN Collaborative Research Group. J Med Genet 1992; 29: 5-11.
32. Sabet A, Li J, Ghandour K, Pu Q, Wu X, Kamholz J, et al. Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B. Neurology 2006; 67: 1141-6.
33. Schenone A, Nobbio L, Mandich P, Bellone E, Abbruzzese M, Aymar F, et al. Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies. Neurology 1997; 48: 445-9.
34. Sereda MW, Meyer zu Horste G, Suter U, Uzma N, Nave KA. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med 2003; 9: 1533-7.
35. Shames I, Fraser A, Colby J, Orfali W, Snipes GJ. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases. J Neuropathol Exp Neurol 2003; 62: 751-64.
36. Sheth S, Francies K, Siskind CE, Feely SME, Lewis R, Shy ME. Diabetes mellitus exacerbates motor and sensory impairment in CMT1A. J Peripher Nerv Sys 2008; 13: 299-304.
37. Shy ME, Arroyo E, Sladky J, Menichella D, Jiang H, Xu W, et al. Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP). J Neuropathol Exp Neurol 1997; 56: 811-21.
38. Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, et al. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 2005; 64: 1209-14.
39. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974; 6: 98-118.
40. Snipes GJ, Suter U. Molecular anatomy and genetics of myelin proteins in the peripheral nervous system. J Anat 1995; 186 (Pt 3):483-94.
41. Snipes GJ, Suter U, Welcher AA, Shooter EM. Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol 1992; 117: 225-38.
42. Stahl N, Harry J, Popko B. Quantitative analysis of myelin protein gene expression during development in the rat sciatic nerve. Brain Res Mol Brain Res 1990; 8: 209-12.
43. Thomas PK, Marques W, Davis MB, Sweeney MG, King RH, Bradley JL, et al. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 1997; 120: 465-78.
44. Trapp BD, Hauer P, Lemke G. Axonal regulation of myelin protein mRNA levels in actively myelinating Schwann cells. J Neurosci 1988; 8: 3515-21.
45. Trapp BD, Pfeiffer SE, Anitei A, Kidd GJ. Cell Biology and myelin assembly. In: Lazzarini RA, editor. Myelin biology and disorders. Vol. 1. San Diego/London: Elsevier Academic Press; 2003. p. 29-56.
46. Vallat JM, Sindou P, Preux PM, Tabaraud F, Milor AM, Couratier P, et al. Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann Neurol 1996; 39: 813-7.
47. Weimer LH, Podwall D. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease. J Neurol Sci 2006; 242: 47-54.
48. Wise CA, Garcia CA, Davis SN, Heju Z, Pentao L, Patel PI, et al. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMTIA duplication. Am J Hum Genet 1993; 53: 853-63.
49. Yoshikawa H, Dyck PJ. Uncompacted inner myelin lamellae in inherited tendency to pressure palsy. J Neuropathol Exp Neurol 1991; 50:649-57.
50. Yoshikawa H, Nishimura T, Nakatsuji Y, Fujimura H, Himoro M, Hayasaka K, et al. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 1994; 35:445-50.